Michael Pancher Selected Research

Adenocarcinoma

5/2016

The GSK3β inhibitor BIS I reverts YAP-dependent EMT signature in PDAC cell lines by decreasing SMADs expression level.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Pancher Research Topics

Disease

3	Neoplasms (Cancer) 11/2022 - 01/2018
2	Glioblastoma (Glioblastoma Multiforme) 03/2023 - 01/2023
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 03/2016
2	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2020 - 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 11/2022
1	Hyperpigmentation 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Neuroblastoma 01/2018
1	Adenocarcinoma 05/2016
1	Motor Neuron Disease (Primary Lateral Sclerosis) 03/2016

Drug/Important Bio-Agent (IBA)

2	Protein Isoforms (Isoforms)IBA 01/2020 - 01/2017
2	Prion ProteinsIBA 01/2020 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 05/2016 - 03/2016
1	arsenicin AIBA 03/2023
1	AdamantaneIBA 03/2023
1	Streptogramin AIBA 01/2023
1	Phenol (Carbolic Acid)FDA Link 11/2022
1	PhytochemicalsIBA 11/2022
1	ApigeninIBA 09/2021
1	HexokinaseIBA 01/2020
1	lonafarnib (SCH 66336)IBA 01/2020
1	Clotrimazole (Lotrimin)FDA LinkGeneric 01/2020
1	Farnesyltranstransferase (Farnesyltransferase)IBA 01/2020
1	PrionsIBA 01/2020
1	ponatinibIBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2017
1	diazonaphthalenedisulfonic acid (NDS)IBA 03/2016
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2016

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2018